Published on
December 10, 2012
- 18:51 GMT
FPRT Bio Awarded Michael J. Fox Foundation Therapeutic Development Initiative Grant
/EINPresswire.com/ New York, NY/Scranton, PA - December 10, 2012 - FPRT Bio, a privately held clinical stage biopharmaceutical company, has been awarded a Therapeutic Development Initiative grant to study molecule, XPro(R)1595, in Parkinson's disease. …
Distribution channels:
Technology